1-Undecanamine
1-Undecanamine structure
|
Common Name | 1-Undecanamine | ||
|---|---|---|---|---|
| CAS Number | 7307-55-3 | Molecular Weight | 171.323 | |
| Density | 0.8±0.1 g/cm3 | Boiling Point | 240.6±3.0 °C at 760 mmHg | |
| Molecular Formula | C11H25N | Melting Point | 15-17 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | 92.2±0.0 °C | |
| Symbol |
GHS05, GHS07, GHS09 |
Signal Word | Danger | |
|
Novel all trans-retinoic Acid derivatives: cytotoxicity, inhibition of cell cycle progression and induction of apoptosis in human cancer cell lines.
Molecules 20 , 8181-97, (2015) Owing to the pharmacological potential of ATRA (all trans-retinoic acid), a series of retinamides and a 1-(retinoyl)-1,3-dicyclohexylurea compound were prepared by reacting ATRA with long chain alkyl or alkenyl fatty amines by using a 4-demethylaminopyridine ... |
|
|
Label-free detection of small-molecule binding to a GPCR in the membrane environment.
Biochim. Biophys. Acta 1854 , 979-86, (2015) Evaluation of drug-target interaction kinetics is becoming increasingly important during the drug-discovery process to investigate selectivity of a drug and predict in vivo target occupancy. To date, it remains challenging to obtain kinetic information for in... |
|
|
Applications of surface plasmon resonance (SPR) for the characterization of nanoparticles developed for biomedical purposes.
Sensors (Basel.) 12 , 16420-32, (2013) Great interest is currently being devoted to the development of nanoparticles (NPs) for biomedical purposes, designed to improve the pharmacokinetic profile of their cargos (either imaging probes or drugs) and to enhance the specific targeting at the disease ... |